(6alpha,11beta,16alpha,17alpha)-6,9-Difluoro-11,17-dihydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carboxylic acid(CAS: 28416-82-2)

This compound falls under the scope of various regulatory guidelines such as the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations, FDA requirements for pharmaceuticals, and EPA regulations for environmental safety. Specific handling, storage, and disposal guidelines must be adhered to based on its hazardous properties.

Several alternatives can be used in the synthesis of this compound, including different reagents such as 17α-ethynylestradiol and analogs like 17α-methyltestosterone. These alternatives can provide similar functional groups with varying properties for different synthetic routes.

Market trends for this compound indicate growing interest in its potential use in pharmaceuticals and research. Research is focusing on its hormonal activity and potential applications in hormone therapy. The compound is also being studied for its pharmacological properties in alternative medicine.

Waste containing this compound should be managed according to environmental protection regulations. Proper waste collection, storage, and disposal should be implemented. Incineration or professional waste disposal services are recommended to ensure the safe and environmentally friendly handling of the waste.